[PLX] QoQ Quarter Result on 30-Jun-2012 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
03-Aug-2012
Financial Year
2012
Quarter
30-Jun-2012 [#Q2]
Profit Trend
QoQ- 263.31%
YoY- 170.44%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Revenue 3,968 48 5,390 26,113 3,728 2,362 1,132 130.57%
PBT -4,321 968 -5,479 22 0 968 0 -
Tax 0 -1,741 -81 -8,765 -161 -27,616 108 -
NP -4,321 -9,877 -5,479 9,642 -5,904 -8,913 -8,875 -38.08%
Tax Rate - 179.86% - 39,840.91% - 2,852.89% - -
Total Cost 8,289 9,925 10,869 16,471 9,632 11,275 10,007 -11.79%
Ratio Analysis
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
NP Margin -108.90 -20,577.08 -101.65 36.92 -158.37 -377.35 -784.01 -73.14%
Per Share
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
EPS -0.05 -1.07 -0.06 0.11 -0.07 -1.01 -0.10 -36.97%
EPS Diluted -0.05 -1.07 -0.06 0.10 -0.07 -1.01 -0.10 -36.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.